ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC

10d ago, source:

Initiated multiple Phase 1b expansion cohorts to determine the RP2D of ORIC-114 in NSCLC patients with EGFR exon 20, HER2 exon 20, or EGFR ...

ORIC Pharmaceuticals: Rally Seems Overdone

27d ago, source: Seeking Alpha

ORIC Pharmaceuticals, Inc. is a South San Francisco based early clinical stage biopharmaceutical concern focused on the development of therapies that counter resistance mechanisms in cancer ...

ORIC Pharmaceuticals gets grant for PLK4 inhibitors for treating cancer

8d ago, source: Pharmaceutical Technology

Discover how ORIC Pharmaceuticals Inc's patent for PLK4 inhibitors could revolutionize cancer treatment. Learn about the compound's potential and pharmaceutical applications.

How Much Upside is Left in Oric Pharmaceuticals (ORIC)? Wall Street Analysts Think 39.3%

1mon ago, source: Yahoo Finance

Oric Pharmaceuticals, Inc. (ORIC) closed the last trading session at $13.46, gaining 12.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...

ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting

17d ago, source:

ORIC-944, a potent and selective allosteric PRC2 inhibitor, demonstrates superior preclinical drug properties and longer clinical half-life which ...

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

20d ago, source: Stockhouse

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address ...

ORIC Pharmaceuticals Inc

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Oric Pharmaceuticals Inc.

1mon ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...